A typical pharmaceutical product may have one or maybe two original oral presentations in its lifecycle at a medical conference
Client had never had a publication accepted for presentation
Client had not cultivated key opinion leader support and feedback
Challenge
Without compelling perceived impact or innovations in displaying data for communication, abstract submissions are unlikely to be accepted
Without relationships with key opinion leaders with name recognition, abstract submissions are less likely to be accepted for the marquee venues such as Late Breaking Sessions
Resolution
In 8 months, garnered 10 scientific oral and late-breaking presentations at top-tier medical conferences from 1 clinical trial dataset